Literature DB >> 15241550

Unraveling the pathogenesis of Parkinson's disease--the contribution of monogenic forms.

V Bonifati1, B A Oostra, P Heutink.   

Abstract

The field of Parkinson's disease pathogenesis is rapidly evolving from the one of a monolithic and obscure entity into the one of a complex scenario with several known molecular players. The ongoing systematic exploration of the genome holds great promise for the identification of the genetic factors conferring susceptibility to the common non-Mendelian forms of this disease. However, most of the progress of the last 5 years has come from the successful mapping and cloning of genes responsible for rare Mendelian variants of Parkinson's disease. These discoveries are providing tremendous help in understanding the molecular mechanisms of this devastating disease. Here we review the genetics of the monogenic forms of Parkinson's disease. Moreover, we focus on the mechanisms of disease caused by alpha-synuclein and parkin mutations, and the implications of this growing body of knowledge for understanding the pathogenesis of the common forms of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241550     DOI: 10.1007/s00018-004-4104-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  2 in total

1.  Can we handle the truth? Legal fictions in the determination of death.

Authors:  Seema K Shah; Franklin G Miller
Journal:  Am J Law Med       Date:  2010

Review 2.  Role of brain death and the dead-donor rule in the ethics of organ transplantation.

Authors:  Robert D Truog; Walter M Robinson
Journal:  Crit Care Med       Date:  2003-09       Impact factor: 7.598

  2 in total
  10 in total

Review 1.  Epidemiological evidence on multiple system atrophy.

Authors:  N Vanacore
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

2.  Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.

Authors:  Hsin F Chien; Christan F Rohé; Maria D L Costa; Guido J Breedveld; Ben A Oostra; Egberto R Barbosa; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2005-11-22       Impact factor: 2.660

3.  Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.

Authors:  Hong Can Zhu; Jing Zhao; Chang Yue Luo; Qian Qian Li
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

Review 4.  Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines.

Authors:  Toshi Nagatsu; Makoto Sawada
Journal:  Cell Mol Neurobiol       Date:  2006-07-06       Impact factor: 5.046

5.  Progress in the genetics of progressive supranuclear palsy: tau gene and beyond.

Authors:  Vincenzo Bonifati
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 5.081

Review 6.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

7.  Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.

Authors:  Cintia Roodveldt; Adahir Labrador-Garrido; Elena Gonzalez-Rey; Rafael Fernandez-Montesinos; Marta Caro; Christian C Lachaud; Christopher A Waudby; Mario Delgado; Christopher M Dobson; David Pozo
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 8.  LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.

Authors:  Vincenzo Bonifati
Journal:  Neurochem Res       Date:  2007-04-18       Impact factor: 3.996

9.  Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice.

Authors:  Thi A Nguyen; Tamy Frank-Cannon; Terina N Martinez; Kelly A Ruhn; Marian Marvin; Bradford Casey; Isaac Treviño; John J Hong; Matthew S Goldberg; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2013-04-28       Impact factor: 8.322

10.  Prodromal non-motor symptoms of Parkinson's disease.

Authors:  Clelia Pellicano; Dario Benincasa; Vincenzo Pisani; Francesca R Buttarelli; Morena Giovannelli; Francesco E Pontieri
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.